Myeloproliferative neoplasm classification: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) |
Gerald Chi (talk | contribs) |
||
| Line 14: | Line 14: | ||
* [[Mastocytosis]] | * [[Mastocytosis]] | ||
:– [[Cutaneous mastocytosis]] | :– [[Cutaneous mastocytosis]] | ||
:– [[Systemic mastocytosis]] | :– [[Systemic mastocytosis]] | ||
:– [[Mast cell leukemia]] | :– [[Mast cell leukemia]] | ||
:– [[Mast cell sarcoma]] | :– [[Mast cell sarcoma]] | ||
:– [[Extracutaneous mastocytoma]] | :– [[Extracutaneous mastocytoma]] | ||
* Myeloproliferative neoplasms, unclassifiable<ref>{{Cite journal| doi = 10.1182/blood-2009-03-209262| issn = 1528-0020| volume = 114| issue = 5| pages = 937–951| last1 = Vardiman| first1 = James W.| last2 = Thiele| first2 = Jüergen| last3 = Arber| first3 = Daniel A.| last4 = Brunning| first4 = Richard D.| last5 = Borowitz| first5 = Michael J.| last6 = Porwit| first6 = Anna| last7 = Harris| first7 = Nancy Lee| last8 = Le Beau| first8 = Michelle M.| last9 = Hellström-Lindberg| first9 = Eva| last10 = Tefferi| first10 = Ayalew| last11 = Bloomfield| first11 = Clara D.| title = The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes| journal = Blood| date = 2009-07-30| pmid = 19357394}}</ref> | * Myeloproliferative neoplasms, unclassifiable<ref>{{Cite journal| doi = 10.1182/blood-2009-03-209262| issn = 1528-0020| volume = 114| issue = 5| pages = 937–951| last1 = Vardiman| first1 = James W.| last2 = Thiele| first2 = Jüergen| last3 = Arber| first3 = Daniel A.| last4 = Brunning| first4 = Richard D.| last5 = Borowitz| first5 = Michael J.| last6 = Porwit| first6 = Anna| last7 = Harris| first7 = Nancy Lee| last8 = Le Beau| first8 = Michelle M.| last9 = Hellström-Lindberg| first9 = Eva| last10 = Tefferi| first10 = Ayalew| last11 = Bloomfield| first11 = Clara D.| title = The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes| journal = Blood| date = 2009-07-30| pmid = 19357394}}</ref> | ||
Revision as of 15:10, 2 April 2015
|
Myeloproliferative Neoplasm Microchapters |
|
Differentiating myeloproliferative neoplasm from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Myeloproliferative neoplasm classification On the Web |
|
American Roentgen Ray Society Images of Myeloproliferative neoplasm classification |
|
Directions to Hospitals Treating Myeloproliferative neoplasm |
|
Risk calculators and risk factors for Myeloproliferative neoplasm classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Classification
WHO Classification of Myeloproliferative Neoplasms (MPN)
- Chronic myelogenous leukemia, BCR-ABL1–positive
- Chronic neutrophilic leukemia
- Polycythemia vera
- Primary myelofibrosis
- Essential thrombocythemia
- Chronic eosinophilic leukemia, not otherwise specified
- Mastocytosis
- – Cutaneous mastocytosis
- – Systemic mastocytosis
- – Mast cell leukemia
- – Mast cell sarcoma
- – Extracutaneous mastocytoma
- Myeloproliferative neoplasms, unclassifiable[1]
References
- ↑ Vardiman, James W.; Thiele, Jüergen; Arber, Daniel A.; Brunning, Richard D.; Borowitz, Michael J.; Porwit, Anna; Harris, Nancy Lee; Le Beau, Michelle M.; Hellström-Lindberg, Eva; Tefferi, Ayalew; Bloomfield, Clara D. (2009-07-30). "The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes". Blood. 114 (5): 937–951. doi:10.1182/blood-2009-03-209262. ISSN 1528-0020. PMID 19357394.